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The pathogenic role of staphylococcal coagulase and clumping factor was investigated in the rat model of
endocarditis. The coagulase-producing and clumping factor-producing parent strain Staphylococcus aureus
Newman and a series of mutants defective in either coagulase, clumping factor, or both were tested for their
ability (i) to attach in vitro to either rat fibrinogen or platelet-fibrin clots and (ii) to produce endocarditis in
rats with catheter-induced aortic vegetations. In vitro, the clumping factor-defective mutants were up to 100
times less able than the wild type strain to attach to fibrinogen and also significantly less adherent than the
parents to platelet-fibrin clots. Coagulase-defective mutants, in contrast, were not altered in their in vitro
adherence phenotype. The rate of in vivo infection was inoculum dependent. Clumping factor-defective mutants
produced ca. 50% less endocarditis than the parent organisms when injected at inoculum sizes infecting,
respectively, 40 and 80% (ID40 and ID80, respectively) of rats with the wild-type strain. This was a trend at the
ID40 but was statistically significant at the ID80 (P < 0.05). Coagulase-defective bacteria were not affected in
their infectivity. Complementation of a clumping factor-defective mutant with a copy of the wild-type clumping
factor gene restored both its in vitro adherence and its in vivo infectivity. These results show that clumping
factor plays a specific role in the pathogenesis of S. aureus endocarditis. Nevertheless, the rate of endocarditis
with clumping factor-defective mutants increased with larger inocula, indicating the contribution of additional
pathogenic determinants in the infective process.
Bacteria which cause infectious endocarditis have the capac-
ity to adhere to damaged cardiac tissue and to platelet-fibrin
clots in vitro (2, 11, 14, 26). Therefore, a likely mechanism for
the initiation of endocarditis is the direct attachment of circu-
lating bacteria to damaged valves (1, 2). Several structures in
the bacterial envelope have been implicated in ligand-receptor
interactions with cardiac vegetations. These have been re-
viewed recently (2) and include polysaccharides, lipoteichoic
acids, proteins in streptococci and enterococci (10, 17, 21, 22,
27, 29), and surface proteins and, possibly, polysaccharides in
staphylococci (6, 9, 19, 30).
Staphylococcus aureus has at least three surface determi-
nants which might mediate adherence to damaged valves and
promote endocarditis, namely, (i) coagulase, which is mainly
secreted in the medium (5, 24), (ii) clumping factor (or fibrin-
ogen-binding protein) (8, 23, 24), and (iii) fibronectin-binding
protein. Recent studies have addressed the roles of these struc-
tures in pathogenesis. Cheung et al. showed that mutants in-
activated in either the sar locus (9) or the sar and agr loci (6),
both of which regulate the expression of several surface pro-
teins, including coagulase, clumping factor, and fibronectin-
binding protein, had a decreased capacity to induce experi-
mental endocarditis in rabbits. In addition, staphylococcal and
streptococcal mutants defective in fibronectin-binding protein
were impeded in their ability to produce experimental endo-
carditis in rats when compared with that of the parental strains
(19, 21). On the other hand, Baddour et al. (3) observed no
decrease in the infectivity of coagulase-defective mutants of S.
aureus, suggesting that coagulase alone is not involved in the
infective process. These important studies shed new light on
the role of adhesins in the pathogenesis of endocarditis. How-
ever, they did not determine the respective significance of
coagulase, clumping factor, and fibronectin-binding protein in
the infective process. Solving this question for S. aureus re-
quires comparison of the infectivities of staphylococcal mu-
tants specifically inactivated in each of the genes concerned,
both singly and in combination.
Recently, the staphylococcal coagulase (coa) and clumping
factor (clfA) genes have been characterized (23, 28), and site-
specific mutants defective in these two determinants have been
generated (23, 24). This allowed further investigation of the
capacity of these components to promote experimental endo-
carditis. In the experiments described here, S. aureus mutants
defective in either the coagulase gene or the clumping factor
gene alone or in both determinants were tested for their ability
to adhere to fibrinogen or platelet-fibrin clots in vitro and to
induce experimental endocarditis in vivo. To confirm the spe-
cific role of clumping factor, we also tested in parallel a clump-
ing factor-negative mutant complemented with a copy of the
cloned clfA gene.
(This study was presented in part at the 34th Interscience
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Conference on Antimicrobial Agents and Chemotherapy, Or-
lando, Fla., 4 to 7 October 1994 [25].)
MATERIALS AND METHODS
Bacterial strains and growth conditions. Strain Newman which produces both
coagulase and clumping factor (13, 24) and site-specific mutants lacking these
factors are listed in Table 1. Strain DU5854 is a coagulase-defective mutant with
a deletion in the coa gene substituted by a fragment encoding tetracycline
resistance (Dcoa::Tcr). The mutation was isolated in strain RN4220 by allelic
replacement and transduced into strain Newman (24). The clumping factor-
defective mutant DU5852 was isolated by transposon Tn917 mutagenesis of
strain Newman (23), forming clfA1::Tn917. The coa clfA double mutant of
Newman (DU5858) was constructed by transducing the clfA1 mutation into
DU5854, selecting for Tcr and Emr. The clfA1 mutation was complemented by
use of a single-copy integration vector, pCL83, carrying the cloned wild-type clfA
gene. The integrant was isolated in RN4220 and transduced into Newman
clfA1::Tn917, selecting for Tcr (DU5896) (20, 23).
Unless otherwise stated, all of the organisms were grown at 378C either on
solid medium (tryptic soy agar; Difco Laboratories, Detroit, Mich.) or in aerated
liquid cultures (tryptic soy broth; Difco) in a rotating incubator at 120 rpm. The
mutant strains were grown in antibiotic-containing medium appropriately sup-
plemented with either 2 mg of tetracycline per ml or 5 mg of erythromycin per ml.
The strains grew at similar rates in liquid cultures, as determined by parallel
increases in optical densities at 620 nm. Frozen stocks of bacteria were kept at
2708C in tryptic soy broth supplemented with 10% glycerol.
Antibiotics and reagents. Erythromycin, tetracycline, and rat fibrinogen were
purchased from Sigma Chemical Co. (St. Louis, Mo.). Rat fibrinogen was sub-
jected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis to test for
purity. Three bands were visualized, as expected for human fibrinogen. Throm-
bin was obtained from Diagnotec (Liestal, Switzerland).
In vitro attachment of bacterial strains to rat fibrinogen. The attachment of
the S. aureus strains was measured by a previously described adhesion assay using
polymethylmethacrylate (PMMA) coverslips coated with purified rat fibrinogen
(23, 24, 32). Two-sided coverslips were coated for 60 min at 378C with increasing
concentrations (from 0.5 to 2 mg/ml) of rat fibrinogen. At the end of the protein
coating phase, the coverslips were rinsed in phosphate-buffered saline (PBS) (23,
24, 32, 33). The adhesion characteristics of the strains were evaluated by incu-
bating the fibrinogen-coated PMMA coverslips for 60 min at 378C with 4 3 106
CFU of washed log-phase cells labelled by growth in Mueller-Hinton broth
containing [3H]thymidine (23, 24, 32, 33). The adhesion medium was PBS with
1 mM Ca21 and 0.5 mM Mg21, supplemented with 5 mg of serum albumin per
ml to prevent nonspecific adhesion of S. aureus (23, 24, 32, 33). In certain
experiments, bacteria were sonicated briefly to disrupt possible clumps. This
procedure did not essentially affect the results. Coverslips were then rinsed, and
the number of attached bacteria was estimated from radioactive counts. Albu-
min-coated coverslips were used as controls (23, 24, 32, 33).
Attachment of S. aureus to protein-coated PMMA coverslips was scored as the
number of adherent CFU 3 103/cm2. The statistical significance of the different
attachment properties of parent and mutant strains was evaluated by one-way
analysis of variance (ANOVA), and pairwise differences between the means of
groups were determined by the t test with the Bonferroni correction. Data were
considered significant when P was ,0.05 by use of two-tailed significance levels.
In vitro attachment to rat platelet-fibrin clots. Adherence to rat platelet-fibrin
clots was measured by slight modifications of a previously described method (26).
First, blood freshly drawn from a pool of donor Wistar rats (weight, 300 to 400
g) was treated with 10% (vol/vol) chloride-citrate buffer (100 mM; pH 4.8) to
prevent coagulation before centrifugation at low speed at room temperature for
5 to 15 min to pellet the erythrocytes and leukocytes. The conditions were set to
keep the platelet counts between 15 3 109 and 50 3 109/liter in the cleared
plasma. Platelet-fibrin clots were produced by pouring 0.5-ml volumes of plasma
into a series of 30-mm-diameter culture plates (Costar Corp., Cambridge, Mass.)
and then adding 100 ml of a 500-U/ml NIH bovine thrombin solution and 100 ml
of a 0.2 mM CaCl2 solution. The components were mixed gently by hand and
allowed to coagulate at room temperature. The clots were then dehydrated
overnight at 378C and kept at 48C before being used. To determine bacterial
adherence, 2-ml volumes of 50 mM sodium phosphate buffer (pH 7) containing
5 3 103 to 1 3 104 CFU/ml were added to the wells (prewarmed at 378C), and
the plates were agitated for 3 min at 120 rpm on a rotating incubator. There was
no difference in levels of clumping of the various test strains as assessed by
phase-contrast microscopy. The fluid was gently decanted, and the clots were
washed twice for 5 min with 2 ml of the same buffer to remove nonadherent
bacteria. The clots were then overlaid with 3 ml of tryptic soy agar, which was
allowed to solidify before incubation at 378C. The number of adherent bacteria
giving rise to colonies was determined after 24 h of incubation and expressed as
the percentage of the number of bacteria in the original inoculum (termed the
adherence ratio). Statistical differences between groups were analyzed as de-
scribed above.
Experimental endocarditis in rats. Sterile aortic vegetations were produced in
female Wistar rats (weight, 200 g) by a previously described method (16). In
brief, a polyethylene catheter (Guerbet Biome´dical, Louvres, France) was in-
serted via the right carotid artery through the aortic valve. The catheter was
secured with a silk ligature and left in place for the remainder of the experiment.
Twenty-four hours after catheterization, groups of rats were inoculated through
a tail vein with 0.5 ml of saline containing different numbers of wild-type strain
Newman cells prepared from a culture in the exponential phase of growth. These
titration experiments allowed the determination of the minimum inoculum of
this organism required to infect 40 to 50% (40% infectious dose [ID40]), 80 to
90% (ID80), or more (43 ID80 to 53 ID80) of the animals. The infectivity of the
mutants was then compared with that of the parent strain by injecting the same
number of cells into groups of 5 to 10 animals. The rats were sacrificed 12 h later,
the aortic valves and vegetations were excised, weighed, and homogenized in 1
ml of saline, and dilutions were plated for colony counts. Mutant bacteria were
plated on both antibiotic-containing and antibiotic-free agars to ascertain the
stability of the markers. Bacterial densities in the vegetations were expressed as
log10 CFU per gram of tissue; $2 log10 CFU/g of vegetation could be detected.
Rats with sterile valve cultures were considered uninfected. Quantitative cultures
of the spleen and qualitative blood cultures were performed in parallel.
Statistical differences between the frequencies of valvular infections were
evaluated by the x2 test with Yates correction. The Bonferroni correction was
used for multiple group comparisons. Differences between mean bacterial den-
sities in infected tissues were analyzed by one-way ANOVA, and pairwise dif-
ferences between the means of groups were determined by the t test with the
Bonferroni correction. Differences between groups were considered significant
when P was #0.05 by use of two-tailed significance levels.
RESULTS
Adherence of S. aureus strains in vitro. Figure 1 shows
that both the ClfA-defective single mutant and the ClfA- and
Coa-defective double mutant were completely defective in at-
tachment to surface-bound rat fibrinogen compared with the
FIG. 1. Attachment properties of parental strain Newman of S. aureus and its
coagulase- and/or clumping factor-defective mutants to PMMA coverslips coated
in vitro with increasing concentrations of purified rat fibrinogen.
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wild-type strain Newman (P , 0.01). In contrast, both the
Coa-defective single mutant and the ClfA-defective mutant
restored with the chromosomally integrated clfA gene showed
no significant decrease in attachment to surface-bound fibrin-
ogen compared with that of the parental strain Newman. Bac-
terial attachment of parental and mutant strains of S. aureus
promoted by rat fibrinogen was equivalent to that of human
fibrinogen (data not shown). These data confirm previous find-
ings that clumping factor, rather than coagulase, was involved
in primary bacterial attachment to fibrinogen in the present
static assay (23, 24, 33) as well as in a recently described
dynamic assay involving shearing flow force to determine in
vitro adherence (12).
Since cardiac vegetations contain numerous proteins and
platelet factors (15) not present in the purified fibrinogen assay
described above, we repeated the adherence experiments with
a more realistic model of platelet-fibrin clots from platelet-
containing rat plasma. Figure 2 shows that the profile of ad-
herence in this assay was similar to that observed on fibrino-
gen-coated coverslips. The coa::Tcr mutation affected neither
the adherence of the wild-type strain Newman nor the adher-
ence of the coa clfA double mutant, indicating that the pro-
duction of coagulase did not contribute to the attachment to
platelet-fibrin clots in vitro. The only notable difference from
the fibrinogen assay was that the clfA1 mutation decreased
adherence by ca. four- to sixfold on platelet-fibrin clots as
compared with ca. 100-fold on pure fibrinogen (Fig. 1). This
might result from the contribution of bacterial adhesins in
platelet-fibrin clots which are not present in purified fibrino-
gen. Note that the adherence ratio of the restored mutant was
slightly greater than that of the parent. Although statistically
significant (P , 0.05), the biological meaning of this small
difference is questionable.
Results of experimental endocarditis. Figure 3 shows the
titration of the infectivity of the various organisms. It can be
seen that the rate of valvular infection increased with the size
of the inoculum. With small inocula, the ClfA-defective mu-
tants tended to produce approximately 50% less endocarditis
than either of the ClfA-producing organisms, including the
parent strain S. aureus Newman, the coagulase-negative (but
clumping-factor-positive) strain DU5854, and the reconsti-
tuted mutant complemented with an extra copy of the clfA
gene. This trend was already observed with the smaller inocu-
lum, which infected ca. 40% of animals challenged with the
control strain Newman (Fig. 3, left panels). The difference
remained proportionally similar and was statistically significant
(P , 0.05) when the size of the inoculum was increased to
infect 80 to 90% of the rats with the ClfA-producing parent
FIG. 3. Infectivity titration of the various test organisms (described in Table
1) in the rat model of experimental endocarditis. The figure shows a compilation
of 12 separate experiments. The rats were challenged with bacterial inocula of
gradually increasing sizes producing rates of endocarditis of ca. 40 and 80% with
the parent strain S. aureus Newman (ID40 and ID80) as well as with an inoculum
four to five times larger than the ID80. The columns indicate the percentage of
positive vegetations (A), blood cultures (B), and spleen cultures (C). The num-
ber of animals per group (n) and the Coa and ClfA phenotypes are indicated at
the bottom of the columns. ND, not determined. The asterisks on the columns
indicate statistically significant differences compared with the parent strain New-
man, as determined by the x2 test with the Yates correction. After correction for
multiple group comparison (Bonferroni), the difference between the parent and
the single ClfA-defective mutant (Coa1 ClfA2 phenotype) remained significant
(P 5 0.03), whereas the difference between the parent and the Coa2 ClfA2
double mutant became marginally significant (P 5 0.08).
FIG. 2. In vitro adherence of the various test organisms (described in Table
1) to platelet-fibrin clots. Two milliliters of sodium phosphate buffer (50 mM; pH
7) containing 5 3 103 to 1 3 104 CFU/ml were added to the clots, and the
mixture was agitated for 3 min at 120 rpm. The clots were rinsed extensively and
overlaid with nutrient agar. Adherent CFUs were counted after 24 h of incuba-
tion at 378C. The figure shows the mean 6 standard deviation of 12 to 24
determinations for each of the test organisms. The bottom of the figure shows the
Coa and ClfA phenotypes of the organisms and the adherence ratio after cor-
rection for the individual inoculum sizes. The asterisks indicate statistically
significant differences (P # 0.05) between groups as determined by one-way
ANOVA and pairwise comparisons using the t test with the Bonferroni correc-
tion.











(Fig. 3, middle panels). However, the difference leveled off as
the inoculum size was further increased another four- to five-
fold (Fig. 3, right panels). This indicated that clumping factor
was not the sole determinant in endocarditis pathogenesis and
that additional elements were also involved in the infectious
process.
In spite of this fact, however, clumping factor clearly played
a pathogenic role since inactivation of its genetic determinant
impeded the ability of the bacteria to infect damaged valves.
This was demonstrated by both the overall profile of inoculum
titration in Fig. 3 and the fact that the infectivity of the defec-
tive mutant could be restored by complementation with a copy
of the wild-type clfA gene (Fig. 3A, middle panel). Deletion of
the coagulase gene, on the other hand, did not decrease the
ability of bacteria to infect cardiac vegetations, whether the
mutation was carried alone or in combination with clumping
factor inactivation. The latter results were in accordance with
recent observations by Baddour et al. (3), who also found that
coagulase inactivation had no effect on experimental endocar-
ditis.
Figure 3 also shows the pattern of positive blood and spleen
cultures at the time of sacrifice, i.e., 12 h after inoculation.
Blood cultures were positive in virtually all of the animals with
infected vegetations, whereas they were sterile in rats with
uninfected valves. Positive blood culture is a classic in bacterial
endocarditis, where circulating microorganisms are constantly
released from infected vegetations. In contrast, spleen cultures
were positive in most of the cases, indicating that this organ
had been successfully colonized by all of the test organisms.
Specific alteration in the infectivity of ClfA-defective mu-
tants. The lower infectivity of the ClfA-defective mutants
might have resulted from either of two alterations which might
operate alone or in combination. First, the ClfA-defective mu-
tants might be altered in their ability to colonize the damaged
valves during the transient bacteremia following intravenous
inoculation. Second, they might have a decreased ability to
multiply in the infected vegetations after having colonized the
valves. To determine which of these two possibilities was re-
sponsible for the decreased infectivity of the ClfA-defective
mutants, the numbers of viable bacteria in the vegetations and
the spleens of the animals at the time of sacrifice were deter-
mined. Table 2 shows that, at the ID80 of the parent strain
Newman, the few animals which developed endocarditis with
the ClfA-defective mutants had vegetations and spleens with
bacterial densities equivalent to those of animals infected with
ClfA1 bacteria (P . 0.05). These infections were not due to
ClfA1 revertants because the bacteria recovered from the veg-
etations retained the Eryr marker. Therefore, growth of ClfA-
defective bacteria in these two sites was not impaired once they
had colonized the valves. This suggests that the ClfA-defective
mutants were most likely hampered in an early step in the
pathogenesis of endocarditis, probably at the stage of coloni-
zation of the damaged valves.
DISCUSSION
The results presented in this paper highlight the respective
roles of coagulase and clumping factor in the pathogenesis of
experimental staphylococcal endocarditis. While coagulase has
been suspected to facilitate infection via its procoagulant and
fibrinogen-binding activity (5), it did not appear to promote
either adherence to platelet-fibrin clots in vitro or experimen-
tal endocarditis in rats in the present experiments. These re-
sults support recent observations with a similar rat model of
experimental endocarditis and Coa-defective staphylococcal
mutants (3). Clumping factor, on the other hand, clearly af-
fected both adherence and valvular infection, as demonstrated
by experiments with the ClfA-defective mutants (and the ClfA-
reconstituted mutant).
There is a theoretical rationale for a pathogenic role for
coagulase in the model. By triggering coagulation, vegetation-
adherent bacteria might promote additional deposits of plate-
lets and fibrin on top of the infection nidus and thus become
protected from further mechanical detachment and/or cellular
host defense mechanisms. Support of this hypothesis was pro-
vided by Herzberg et al. (17), who showed that streptococcal
mutants affected in the production of surface proteins medi-
ating platelet aggregation (Agg-negative phenotype) were less
virulent and produced smaller vegetations than Agg1 parent
strains in the rabbit model of endocarditis. Thus, it was some-
what unexpected that in the present experiments, staphylo-
coccal coagulase did not play a role in the pathogenesis of
endocarditis. However, the staphylococcal and streptococcal
investigations outlined above may not be directly comparable.
Indeed, not only did they test different organisms which ex-
pressed quite different procoagulant activities (i.e., fibrinogen
polymerization for staphylococci versus platelet aggregation
for streptococci), but they also used different study designs. By
killing the animals soon after inoculation (12 h postchallenge
in the present experiments), the researchers in the staphylo-
coccal experiments investigated whether coagulase could affect
the early establishment of valvular infection. They did not,
however, determine the impact of coagulase on more-ad-
vanced disease. In the streptococcal investigation, on the other
hand, the animals were killed between 1 and 4 days after
inoculation and provided a glimpse at a later stage of infection.
Thus, while the available experimental data clearly demon-
strated that the staphylococcal coagulase did not affect the
initiation of experimental endocarditis, they did not rule out a
role of coagulase in the later infection. Further investigations
will be necessary to clarify this issue.
Clumping factor is different from coagulase because it is
TABLE 2. Bacterial densities in vegetations and spleens of rats which developed experimental endocarditis after challenge
with inoculum sizes equal to the ID80 of the parent strain Newman
Infection site











Vegetations 6.45 6 1.47 (19) 6.10 6 1.5 (7) 6.50 6 1.6 (9) 7.01 6 0.8 (6) 7.91 6 1.22 (10)
Spleens 3.73 6 0.69 (19) 3.71 6 0.79 (7) 3.77 6 0.68 (8)d 3.10 6 0.90 (6) 3.85 6 0.69 (10)
a Bacterial density is expressed as log10 CFU per gram of tissue. The numbers in parentheses represent the numbers of animals. Differences between values were
not statistically different (P . 0.05) as analyzed by one-way ANOVA.
b Phenotypes are shown in parentheses after strain designations.
c clfA1::Tn917 mutant complemented with a copy of the cloned clfA gene.
d One rat had no spleen culture.











attached to the bacterial surface (23, 24) and mediates direct
adherence to fibrinogen and fibrin, which are present in large
amounts in the vegetation. Clumping factor also mediates
platelet aggregation (4), which is another major factor in the
constitution of cardiac vegetations. Alteration of clumping fac-
tor decreased both bacterial adherence to rat fibrinogen and
platelet-fibrin clots in vitro as well as the ability of bacteria to
infect damaged valves in vivo. In addition, the adherence and
infectivity of ClfA-defective mutants could be restored by
complementation of these organisms with the wild-type clfA
gene, providing further support for a specific role of clumping
factor in the staphylococcal pathogenicity. The lower infectivity
of the mutants was not due to a decreased bacterial fitness in
vivo, as ClfA-defective mutants grew well in cardiac vegeta-
tions of those animals which became infected with the defec-
tive strains. Therefore, ClfA-defective mutants were not al-
tered in their potential to maintain an established infection but
rather in their capacity to infect sterile vegetations.
An additional argument for the specific role of clumping
factor in valve infection was that the spleens were equally
colonized by parents and ClfA-defective mutants. After inoc-
ulation, circulating bacteria are trapped in the spleen, where
they are eventually phagocytized. Lower spleen bacterial den-
sities after challenge with ClfA-defective mutants would have
suggested faster clearance of the mutants than of the parent
strain by host defense mechanisms and introduced a bias in the
experimental system. Thus, a likely explanation for the lower
infectivity of the defective mutants is that they were specifically
impeded in their ability to colonize and infect damaged valves
but not in their overall resistance to cellular host defenses.
Whether this involves primarily adherence to fibrinogen, ad-
herence and triggering of platelet aggregation, or both remains
to be determined.
The probability of valvular infection depends on both the
magnitude of postchallenge bacteremia and the ligand-recep-
tor interactions between bacterial surface components and
constituents of damaged valves. This was exemplified in the
last series of experiments, showing that inoculation of greater
numbers of ClfA-defective mutants resulted in an increased
rate of infection. This was also demonstrated by experiments
using mutants and double mutants in the sar and agr global
regulatory loci (6, 9). The sar and agr mutants are affected in
the expression of numerous secreted and surface-bound pro-
teins, including hemolysins, coagulase, clumping factor, and
fibrinogen-binding proteins (7, 18). The sar mutants were al-
tered in their ability both to adhere to damaged valves and to
induce experimental endocarditis (9). In addition, when both
sar and agr were inactivated, the infectivity of the double mu-
tants was further reduced (6), suggesting that the sar and agr
mutations had an additive, if not synergistic, effect on patho-
genesis. This supports the hypothesis that several staphylococ-
cal surface structures are involved in the initiation of endocar-
ditis and cooperate to promote infection.
Unraveling the molecular mechanisms of staphylococcal
pathogenesis carries the hope of generating new antistaphylo-
coccal prophylactic and/or therapeutic alternatives. Not only
are there multiple surface determinants to consider, but the
strategies to block these components and their beneficial effect
for the patient have yet to be defined. As in the experimental
model, colonization of endovascular lesions or prostheses in
humans is a yes-or-no phenomenon arising during transient
low-grade bacteremia, which often occurs spontaneously. Al-
teration of staphylococcal adherence in vivo could possibly be
achieved by a variety of means, including vaccination against
specific bacterial determinants or devising prosthetic material
with antiadherent properties. Indeed, the adherence of certain
staphylococci and group B streptococci to fibrinogen or fi-
bronectin can vary with the physicochemical state of these
molecules, depending on whether they are in soluble form or
attached to specific supports (31, 33). Since foreign material
becomes coated rapidly with fibrin-fibrinogen, fibronectin, and
other plasma proteins soon after implantation, bacterial ad-
herence might be modulated by designing new surfaces which
would force these adherent molecules to expose nonadherent
domains once attached to prosthetic material.
In summary, the present experiments demonstrate that clump-
ing factor has a specific role in the pathogenesis of staphylo-
coccal endocarditis. Moreover, they underline the involvement
of additional bacterial surface determinants in the infectious
process, as recently suggested by studies with the pleiotropic
sar and agrmutants (6, 9). The prospect of obtaining single and
multiple mutants in each of these pathogenic factors will help
further define the most appropriate bacterial target(s) for the
future development of new antistaphylococcal agents.
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